J&J Faces Growing Threat In Ditropan XL Litigation

Law360, New York (April 26, 2006, 12:00 AM EDT) -- The ranks of plaintiffs in a class action suit alleging that Mountain View, Calif.-based Alza Corporation monopolized the market for a bladder control drug grew Tuesday, when a judicial panel added a case from Tennessee to the pool of aggrieved litigants.

The Judicial Panel on Multidistrict Litigation transferred the case—Jabo’s Pharmacy Inc. v. Johnson & Johnson et al.—to California’s Northern District at the request of Alza. This is the fourth case against Alza to be consolidated.

The panel based its decision on its finding that “these...
To view the full article, register now.